Literature DB >> 343541

Use of hematin in the acute attack of the "inducible" hepatic prophyrias.

C J Watson, C A Pierach, I Bossenmaier, R Cardinal.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1978        PMID: 343541

Source DB:  PubMed          Journal:  Adv Intern Med        ISSN: 0065-2822


× No keyword cloud information.
  7 in total

1.  Haem arginate in the treatment of acute hepatic porphyrias.

Authors:  P Mustajoki; R Tenhunen; O Tokola; G Gothoni
Journal:  Br Med J (Clin Res Ed)       Date:  1986-08-30

2.  Coexistence of hereditary coproporphyria and epilepsy: coproporphyrinogen oxidase deficiency in liver and kidney.

Authors:  M Doss; R von Tiepermann; K H Pflüger
Journal:  J Neurol       Date:  1981       Impact factor: 4.849

3.  Hematin therapy in porphyric attacks.

Authors:  C A Pierach; I Bossenmaier; R Cardinal; M Weimer; C J Watson
Journal:  Klin Wochenschr       Date:  1980-08-15

4.  Control of delta-aminolaevulinate synthase and haem oxygenase in chronic-iron-overloaded rats.

Authors:  N G Ibrahim; J C Nelson; R D Levere
Journal:  Biochem J       Date:  1981-10-15       Impact factor: 3.857

5.  Hematin-derived anticoagulant. Generation in vitro and in vivo.

Authors:  R L Jones
Journal:  J Exp Med       Date:  1986-03-01       Impact factor: 14.307

6.  Pathogenesis and treatment of acute intermittent porphyria: discussion paper.

Authors:  A C Laiwah; A Goldberg; M R Moore
Journal:  J R Soc Med       Date:  1983-05       Impact factor: 18.000

Review 7.  Therapy Follows Diagnosis: Old and New Approaches for the Treatment of Acute Porphyrias, What We Know and What We Should Know.

Authors:  Petro E Petrides
Journal:  Diagnostics (Basel)       Date:  2022-07-03
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.